Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study

Bone

Volumn 48, Issue 2, 2011, Pages 218-224

  Szabo, K A ^a   Webber, C E ^a   Adachi, J D ^a   Tozer, R ^a   Gordon, C ^a   Papaioannou, A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anastrozole; Breast cancer; Cortical bone; Peripheral Quantitative Computed Tomography (pQCT); Postmenopausal women; Trabecular bone

Indexed keywords

ANASTROZOLE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL BONE; DRUG EFFECT; EPIPHYSIS; FEMALE; HUMAN; PERIPHERAL QUANTITATIVE COMPUTER ASSISTED TOMOGRAPHY; POSTMENOPAUSE; RADIUS; TIBIA; TRABECULAR BONE; VOLUMETRY;

AGED; AGED, 80 AND OVER; AROMATASE INHIBITORS; BONE DENSITY; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NITRILES; POSTMENOPAUSE; RADIUS; TIBIA; TRIAZOLES;

EID: 78650977200     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.09.025     Document Type: Article

References (20)

1. Heshmati H.M., Khosla S., Robins S.P., O'Fallon W.M., Melton L.J., Riggs B.L. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 2002, 17:172-178.
2. Eastell R., Hannon R.A., Cuzick J., Dowsett M., Clack G., Adams J.E. ATAC Trialists' Group, Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial. J Bone Miner Res 2006, 21:1215-1223.
3. Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. ATAC Trialists' Group, Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5years' adjuvant treatment for breast cancer. Lancet 2005, 365:60-62.
4. Thürlimann B., Keshaviah A., Coates A.S., Mouridsen H., Mauriac L., et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005, 353:2747-2757. Breast International Group (BIG) 1-98 Collaborative Group.
5. Coates A.S., Keshaviah A., Thürlimann B., Mouridsen H., Mauriac L., Forbes J.F., et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol. 2007, 25:486-492.
6. Jakesz R., Jonat W., Gnant M., Mittlboeck M., Greil R., Tausch C., et al. ABCSG and the GABG, Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 2005, 366:455-462.
7. Goss P.E., Ingle J.N., Martino S., Robert N.J., Muss H.B., Piccart M.J., et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003, 349:1793-1802.
8. Perez E.A., Josse R.G., Pritchard K.I., Ingle J.N., Martino S., Findlay B.P., et al. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol 2006, 24:3629-3635.
9. Coleman R.E., Banks L.M., Girgis S.I., Kilburn L.S., Vrdoljak E., Fox J., et al. Intergroup Exemestane Study group., Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study. Lancet Oncol 2007, 8:119-127.
10. Ferretti J.L., Capozza R.F., Zanchetta J.R. Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength. Bone 1996, 18:97-102.
11. Eastell R., Riggs B.L., Wahner H.W., O'Fallon W.M., Amadio P.C., Melton L.J. Colles' fracture and bone density of the ultradistal radius. J Bone Miner Res 1989, 4:607-613.
12. Borah B., Gross G.J., Dufresne T.E., Smith T.S., Cockman M.D., Chmielewski P.A., et al. Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anat Rec 2001, 265:101-110.
13. Black D.M., Cummings S.R., Melton L.J. Appendicular bone mineral and a woman's lifetime risk of hip fracture. J Bone Miner Res 1992, 7:639-646.
14. Earnshaw S.A., Cawte S.A., Worley A., Hosking D.J. Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate. Osteoporos Int 1998, 8:53-60.
15. Gay J.D. Radial fracture as an indicator of osteoporosis: a 10-year follow-up study. Can Med Assoc J 1974, 111:156-157.
16. Mallmin H., Ljunghall S., Persson I., Naessen T., Krusemo U.B., Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24years of follow-up. Calcif Tissue Int 1993, 52:269-272.
17. Lauritzen J.B., Schwarz P., McNair P., Lund B., Transbøl I. Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation. Osteoporos Int 1993, 3:133-137.
18. Cuddihy M.T., Gabriel S.E., Crowson C.S., O'Fallon W.M., Melton L.J. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int 1999, 9:469-475.
19. Gardsell P., Johnell O., Nilsson B.E., Gullberg B. Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcif Tissue Int 1993, 52:348-353.
20. Melton L.J., Atkinson E.J., O'Fallon W.M., Wahner H.W., Riggs B.L. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993, 8:1227-1233.